Effects of vitamin E on endothelial function in men after myocardial infarction

T G Elliott1, J D Barth, G B Mancini

  • 1Department of Medicine, University of British Columbia, Vancouver, Canada.

Insights

Endothelial dysfunction is common after myocardial infarction. Three months of vitamin E therapy did not improve endothelial function in men post-heart attack, suggesting further research is needed.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Nutritional Science

Background:

  • Endothelial dysfunction is a key factor in cardiovascular disease progression.
  • Myocardial infarction (MI) can lead to persistent endothelial dysfunction.
  • Antioxidants are investigated for their potential to mitigate vascular damage.

Purpose of the Study:

  • To assess endothelial function in men 3-6 months after myocardial infarction.
  • To evaluate the efficacy of vitamin E supplementation in improving endothelial function post-MI.

Main Methods:

  • Study population: Men 3-6 months post-myocardial infarction.
  • Intervention: Daily supplementation with vitamin E (800 IU/day) for 3 months.
  • Assessment: Measurement of endothelial function parameters.

Main Results:

  • Endothelial dysfunction was confirmed in men 3-6 months after myocardial infarction.
  • No significant improvement in endothelial function was observed after 3 months of vitamin E therapy.
  • The study did not demonstrate a benefit of vitamin E at 800 IU/day for endothelial function post-MI.

Conclusions:

  • Vitamin E (800 IU/day) for 3 months is insufficient to improve endothelial function in men after myocardial infarction.
  • Further investigation is warranted for higher vitamin E doses, longer treatment durations, or alternative antioxidant therapies.
  • Exploring agents with lipid-modifying activity alongside antioxidants may be beneficial for vascular health post-MI.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...